Welcome to our dedicated page for Cardiocomm Solut news (Ticker: EKGGF), a resource for investors and traders seeking the latest updates and insights on Cardiocomm Solut stock.
CardioComm Solutions, Inc. reports developments as a healthcare technology company focused on medical electrocardiogram software, consumer heart monitoring, remote patient monitoring and cardiac data-management platforms. Its updates commonly cover GEMS FLEX, 14-day Holter and Event long-term continuous monitoring ECG software, HeartCheck CardiBeat monitoring, SMART Monitoring ECG services and integrations that connect ECG data with wearable or remote-care workflows.
Company news also includes financing and capital-structure actions, such as loan facilities, debt settlements, related-party transactions, stock options and insider debt ownership, along with TSX Venture Exchange approvals and reporting framework changes. CardioComm’s releases describe medical-device clearances and sales licenses in the United States and Canada, ISO 13485 and ISO 27001 certifications, and HIPAA-compliant software operations.
Summary not available.
Summary not available.
Summary not available.
Summary not available.